Personal and Professional: An Immunologist’s Quest to Cure HIV
June 23, 2023
To celebrate Pride Month, Enterprise Innovation spoke with Dr. Brad Jones, an associate professor of immunology in medicine, about his mission to find a cure for HIV and the recent progress in his research.
Scientists Pitch Medical Innovations at 2023 Biomedical Business Plan Challenge
June 16, 2023
Standing on the stage at Uris Auditorium on June 1, Dr. Joe Zhou, an associate professor in regenerative medicine in medicine at Weill Cornell Medicine, made the case for the necessity of developing new approaches to treat diabetes, a disease he called “a true epidemic of the modern world.”
Biomedical Engineering Symposium Showcases Research, Facilitates Collaborations
June 15, 2023
A two-day intercampus event, the “Biomedical Engineering Symposium: Tools to Transform Discovery and Care,” brought together dozens of engineers, scientists and practitioners from across Cornell to share research and foster collaborations, with the goal of building the foundation for new, cutting-edge medical treatments and devices.
Cornell Engineering and Weill Cornell Medicine Pilot M.D.-M.Eng. Degree
May 10, 2023
As part of a new cross-college initiative designed to accelerate engineering innovations in medicine, Cornell Engineering is piloting an M.D.-M.Eng. program that allows medical students at Weill Cornell Medicine to earn a one-year professional Master of Engineering degree while they are in medical school.
App-Based Communication Tool Receives NIH Funding
May 8, 2023
VoiceLove LLC, a startup founded by two Weill Cornell Medicine physicians, was awarded a $3 million fast-track Phase 1-Phase 2 grant by the National Institute on Aging of the National Institutes of Health to further develop and test in clinical trial a prototype app designed to help critically ill patients in hospital intensive care units connect with their families.
Biotechnology Company Founded on Weill Cornell Technology Announced $90 Million Series A Financing to Advance Radioantibody Treatment for Cancer
May 8, 2023
Convergent Therapeutics Inc., a clinical-stage biotechnology company co-founded by Dr. Neil Bander, the Bernard and Josephine Chaus Professor of Urologic Oncology, announced May 3 the completion of a $90 million Series A financing. Convergent focuses on developing next-generation radiopharmaceuticals for the treatment of cancer. The financing will support its development of a pipeline of novel radioantibodies, including its lead program with CONV01-α, for the treatment of advanced prostate cancer.
Robert Langer ’70 Receives Engineering’s Highest Alumni Honor
April 21, 2023
He is the most cited engineer in history. He holds more than 1,400 patents. His pioneering work in biotechnology, drug delivery and tissue engineering has made him one of the most prolific inventors in medicine, and he has co-founded more than 40 companies, including Moderna. For this and many other achievements, Robert Langer ’70 received the Cornell Engineering Distinguished Alumni Award during a celebration hosted Apr. 19 in the Duffield Hall Atrium at Cornell University.
Bioentrepreneurship Initiative Fosters Entrepreneurial Community
April 12, 2023
Members of the Cornell entrepreneurial community gathered to celebrate a successful first year of the BioEntrepreneurship Initiative at the program’s culminating workshop on March 18 at Cornell’s academic space in Midtown Manhattan. In its inaugural year, the program of the Cornell SC Johnson College of Business unified MBA students and researchers to develop the next generation of life-science startup C-suite leaders and encouraged collaboration between Cornell’s Ithaca and New York campuses.
Student Teams Tackle Pressing Health Concerns During Health Hackathon
March 30, 2023
Asthma is personal for Tyler Bershad. “Like 26 million Americans, I have asthma,” said Bershad, an MBA candidate in business administration at Cornell Tech, during the 2023 Health Hackathon in February. “Asthma is the most prevalent chronic respiratory disease in humans and, unfortunately, those who are most vulnerable are children.”
3D-Printed Scaffold Could Improve Breast Reconstruction Results
March 8, 2023
Weill Cornell Medicine investigators have developed a technique to help surgeons reconstruct more natural-looking nipples for patients who have undergone breast reconstruction after mastectomy to treat breast cancer.